FDA Approves Nintedanib for SSc-ILD, But Temper Your Expectations
Nintedanib Slows Lung Deterioration in General Fibrosing Interstitial Lung Disease
Simple Tasks
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
American College of Rheumatology
Visit the official website for the American College of Rheumatology.